190 related articles for article (PubMed ID: 38490099)
21. MicroRNAs involved in regulating epithelial-mesenchymal transition and cancer stem cells as molecular targets for cancer therapeutics.
Xia H; Hui KM
Cancer Gene Ther; 2012 Nov; 19(11):723-30. PubMed ID: 22975591
[TBL] [Abstract][Full Text] [Related]
22. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
Hong IS; Lee HY; Nam JS
Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
[TBL] [Abstract][Full Text] [Related]
23. Natural Products That Target Cancer Stem Cells.
Moselhy J; Srinivasan S; Ankem MK; Damodaran C
Anticancer Res; 2015 Nov; 35(11):5773-88. PubMed ID: 26503998
[TBL] [Abstract][Full Text] [Related]
24. The cancer stem-cell hypothesis: its emerging role in lung cancer biology and its relevance for future therapy.
O'Flaherty JD; Barr M; Fennell D; Richard D; Reynolds J; O'Leary J; O'Byrne K
J Thorac Oncol; 2012 Dec; 7(12):1880-1890. PubMed ID: 23154562
[TBL] [Abstract][Full Text] [Related]
25. Biomarkers and targeted therapy for cancer stem cells.
Liu Y; Wang H
Trends Pharmacol Sci; 2024 Jan; 45(1):56-66. PubMed ID: 38071088
[TBL] [Abstract][Full Text] [Related]
26. MiR-4319 Suppress the Malignancy of Triple-Negative Breast Cancer by Regulating Self-Renewal and Tumorigenesis of Stem Cells.
Chu J; Li Y; Fan X; Ma J; Li J; Lu G; Zhang Y; Huang Y; Li W; Huang X; Fu Z; Yin Y; Yuan H
Cell Physiol Biochem; 2018; 48(2):593-604. PubMed ID: 30021199
[TBL] [Abstract][Full Text] [Related]
27. MiR-24 induces chemotherapy resistance and hypoxic advantage in breast cancer.
Roscigno G; Puoti I; Giordano I; Donnarumma E; Russo V; Affinito A; Adamo A; Quintavalle C; Todaro M; Vivanco MD; Condorelli G
Oncotarget; 2017 Mar; 8(12):19507-19521. PubMed ID: 28061479
[TBL] [Abstract][Full Text] [Related]
28. Targeting breast cancer stem cells.
McDermott SP; Wicha MS
Mol Oncol; 2010 Oct; 4(5):404-19. PubMed ID: 20599450
[TBL] [Abstract][Full Text] [Related]
29. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
Fanale D; Barraco N; Listì A; Bazan V; Russo A
Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
[TBL] [Abstract][Full Text] [Related]
30. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
[TBL] [Abstract][Full Text] [Related]
31. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
[TBL] [Abstract][Full Text] [Related]
32. Overview of cancer stem cells (CSCs) and mechanisms of their regulation: implications for cancer therapy.
Bao B; Ahmad A; Azmi AS; Ali S; Sarkar FH
Curr Protoc Pharmacol; 2013 Jun; Chapter 14():Unit 14.25. PubMed ID: 23744710
[TBL] [Abstract][Full Text] [Related]
33. Breast cancer stem cells: A review of their characteristics and the agents that affect them.
Shan NL; Shin Y; Yang G; Furmanski P; Suh N
Mol Carcinog; 2021 Feb; 60(2):73-100. PubMed ID: 33428807
[TBL] [Abstract][Full Text] [Related]
34. New approaches to target cancer stem cells: current scenario.
Insan MB; Jaitak V
Mini Rev Med Chem; 2014 Jan; 14(1):20-34. PubMed ID: 24195662
[TBL] [Abstract][Full Text] [Related]
35. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.
Zhang H; Li W; Nan F; Ren F; Wang H; Xu Y; Zhang F
Biochem Biophys Res Commun; 2011 Jan; 404(1):273-8. PubMed ID: 21130073
[TBL] [Abstract][Full Text] [Related]
37. Therapeutic potential of cancer stem cells.
Yang C; Jin K; Tong Y; Cho WC
Med Oncol; 2015 Jun; 32(6):619. PubMed ID: 25920610
[TBL] [Abstract][Full Text] [Related]
38. Differences and similarities between cancer and somatic stem cells: therapeutic implications.
Rossi F; Noren H; Jove R; Beljanski V; Grinnemo KH
Stem Cell Res Ther; 2020 Nov; 11(1):489. PubMed ID: 33208173
[TBL] [Abstract][Full Text] [Related]
39. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.
Bourguignon LY; Wong G; Earle C; Chen L
J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005
[TBL] [Abstract][Full Text] [Related]
40. The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.
Cioffi M; Trabulo SM; Sanchez-Ripoll Y; Miranda-Lorenzo I; Lonardo E; Dorado J; Reis Vieira C; Ramirez JC; Hidalgo M; Aicher A; Hahn S; Sainz B; Heeschen C
Gut; 2015 Dec; 64(12):1936-48. PubMed ID: 25887381
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
